- Home
- About ASF
- What is Autism?
- How Common is Autism?
- Signs and Symptoms of Autism
- Autism Diagnosis
- Following a Diagnosis
- Treatment Options
- Beware of Non-Evidence-Based Treatments
- Statement on Use of Medical Marijuana for People with Autism
- Autism and Vaccines
- Autism Science
- Quick Facts About Autism
- What We Fund
- Get Involved
- Resources
- COVID-19 Resources
- Day of Learning
- Contact Us
Research by Topic: Risperidone
Is Medication Information for Children with Autism Spectrum Disorder Monitored and Coordinated Across Professionals? Findings from a Teacher Survey
Published March 1, 2013 in School Mental HealthThis study examined school-based medication monitoring in children with ASD. Researchers found that less than half of teachers of medicated students were aware that students were taking medication and no teachers were communicating with prescribing physicians about student behavior and side effects. Since monitoring medication across settings helps physicians assess drug safety and effectiveness, the authors argue for increased communication among professionals.
http://link.springer.com/article/10.1007/s12310-012-9098-5
Filed under: Autism Research, Autism Science, Behavior, featured, Risperidone, Treatment, Treatments
Meta-Analysis of The Effects of Risperidone or Aripiprazole on Individuals with ASD
Published January 1, 2013 in Research in Autism Spectrum DisordersThis study analyzes the efficacy and secondary effects of the drugs, Risperidone and Aripipazole.
http://www.sciencedirect.com/science/article/pii/S1750946712000943
Filed under: Autism News, Autism Research, Autism Science, Risperidone
Treatments Show Promise in Reducing Autism-related Behaviors, but Some have Significant Side Effects
Published April 4, 2011 in Agency for Heathcare Research and QualitySome medical and behavioral treatments show promise for reducing certain behaviors in children with autism spectrum disorders (ASDs), but more research is needed to assess the potential benefits and harms, according to a new report funded by HHS’ Agency for Healthcare Research and Quality (AHRQ). The research results were published online in the journal Pediatrics.
http://www.ahrq.gov/news/press/pr2011/autismpr.htm
Filed under: Early Intervention, Psychopharmacology, Risperidone, Treatments
A Systematic Review of Medical Treatments for Children with Autism Spectrum Disorders
Published April 1, 2011 in Pediatrics, McPheeters et al.Researchers at Vanderbilt University reviewed evidence regarding medical treatment of children 12 years old and younger with an Autism Spectrum Disorder (ASD). It was found that risperidone and aripiprazole for treatment of challenging and repetitive behaviors in children with ASDs. However, there are significant adverse effects of these medicines, including severe impairment or risk of […]
American Academy of Pediatrics
Filed under: Behavior, featured, Psychopharmacology, Repetitive Behavior, Risperidone, Treatments
Moderators, Mediators,and Other Predictors of Risperidone Response in Children with Autistic Disorder and Irritability
Published April 1, 2010 in Journal of Childhood and Adolescent Psychopharmacology, Arnold et alThe National Institute of Mental Health (NIMH) Research Units on Pediatric Psychopharmacology (RUPP) Autism Network found an effect size of d = 1.2 in favor of risperidone on the main outcome measure in an 8-week double-blind, placebo-controlled trial for irritability in autistic disorder. This paper explores moderators and mediators of this effect. This study found […]
http://www.ncbi.nlm.nih.gov/pubmed/20415603
Filed under: Irritability, Psychopharmacology, Risperidone, Treatments